David Tuller
Trial By Error: UK Funds Genetics Project; My Letter to CODES Investigators
By David Tuller
By David Tuller, DrPH UK Funding for Major Genetics ME Study Two of the UK's largest public funding agencies announced this week that they would provide £3.2 million (around $4 million at current rates) for a study that will analyze genetic material from as many as 20,000 people to search ...
Trial By Error: More Questions About CODES Trial of CBT for Seizures
By David Tuller
By David Tuller, DrPH [*In the last paragraph, I mistakenly referred to the CODES protocol rather than the CODES statistical analysis plan. I apologize for the error.] I have recently written about CODES, the high-profile clinical trial investigating whether cognitive behavior therapy (CBT) could reduce the frequency of dissociative seizures, ...
Trial By Error: BMJ Responds to Appeals About Norway’s CBT-Music Therapy Study
By David Tuller
By David Tuller, DrPH Earlier this week, I sent a nudge to Professor Imti Choonara, editor-in-chief of BMJ Paediatrics Open, and Fiona Godlee, editorial director of BMJ, about a problematic "feasibility study" published a few months ago. That followed a letter two weeks ago, to which I had not received ...
Trial By Error: Trio of Trials Shows Limits of CBT for Medically Unexplained Symptoms
By David Tuller
Lancet Psychiatry recently published the results of a high-profile trial of cognitive behavior therapy as a treatment for so-called dissociative seizures, also known as psychogenic non-epileptic seizures. The trial, nicknamed CODES, found that CBT had no impact on seizure frequency--the primary outcome. The average number of seizures per month dropped ...
Trial By Error: A Letter to KCL, Another Letter to BMJ
By David Tuller
By David Tuller, DrPH Last week, I wrote about a troubling press release issued by King's College London regarding a major study of cognitive behavioural therapy as a treatment for so-called dissociative seizures. On Friday, I sent a letter to the two communications people listed on the press release about ...
